Aspirin Antiplatelet Therapy and Dental Treatment

Drug: Aspirin / Acetylsalicylic Acid / ASA

German terms: ASS, Acetylsalicylsäure, Thrombozytenaggregationshemmer, Blutungsrisiko, lokale Hämostase

Category: Antiplatelet medication; irreversible cyclooxygenase-1 inhibitor affecting platelet aggregation

Common antiplatelet dose: low-dose aspirin, commonly around 75–100 mg daily depending on country and indication

Dental relevance: planning extractions, periodontal surgery, implant surgery, biopsies, subgingival instrumentation, and postoperative bleeding control.

This article is for dental education only. Do not tell a patient to stop aspirin used for cardiovascular or cerebrovascular protection without clear medical guidance. Stopping antiplatelet therapy can expose the patient to serious thrombotic risk such as myocardial infarction, stroke, or stent thrombosis. For most dental procedures, bleeding can be managed with careful planning and local haemostatic measures.

Aspirin reduces platelet aggregation by irreversibly inhibiting platelet cyclooxygenase-1. Because platelets cannot make new enzyme, the antiplatelet effect lasts for the life of the platelet.

In dentistry, aspirin may increase postoperative bleeding, especially after invasive procedures. However, for most patients, the risk of stopping aspirin is more dangerous than the usually controllable dental bleeding risk.

The key clinical principle is: do not stop aspirin casually; assess the procedure, control bleeding locally, and consult when the case is complex.

• Best dental approach: usually continue aspirin and use local haemostatic measures.
• Main dental risk: prolonged oozing or postoperative bleeding after invasive treatment.
• Main medical risk if stopped: myocardial infarction, stroke, stent thrombosis, or recurrent vascular event.
• Key dental action: identify whether aspirin is single therapy or part of dual antiplatelet therapy.
• Clinical priority: stage extensive treatment and achieve stable haemostasis before discharge.

Aspirin blocks platelet thromboxane A2 production. This reduces platelet activation and aggregation, which is useful for preventing arterial clotting events.

• Platelet effect: reduced platelet plug formation.
• Dental effect: possible longer bleeding time after surgical procedures.
• Medical benefit: protection against thrombotic cardiovascular and cerebrovascular events in selected patients.
• Duration: platelet function recovers gradually as new platelets are produced.
• Important: a normal-looking extraction site can still rebleed if the patient rinses vigorously, smokes, or dislodges the clot.

• Aspirin monotherapy: treat without interrupting the antiplatelet medication for dental procedures.
• Dual antiplatelet therapy: do not stop casually; manage bleeding locally and consult if procedure or medical risk is high.
• Low bleeding risk procedures: usually proceed with local measures and clear instructions.
• Higher bleeding risk procedures: consider staging, limiting the surgical area, suturing, packing, and careful follow-up.
• Never improvise: recent stents, recent stroke, recent myocardial infarction, and combination antithrombotic therapy need extra caution.

• Unlikely to cause bleeding: examination, radiographs, supragingival restorations, impressions, simple prosthetic adjustments, and many local anesthesia injections.
• Low postoperative bleeding risk: simple extraction of 1–3 teeth, limited subgingival debridement, simple incision and drainage, and small soft-tissue procedures.
• Higher bleeding risk: multiple adjacent extractions, flap procedures, periodontal surgery, implant surgery, biopsies, gingival recontouring, crown lengthening, and periradicular surgery.
• Clinical reality: aspirin becomes more important when combined with other antithrombotic drugs or patient factors such as liver disease, thrombocytopenia, or previous bleeding.

• Confirm whether aspirin is taken as antiplatelet therapy, analgesic self-medication, or part of dual antiplatelet therapy.
• Document the dose, frequency, indication, and prescribing clinician when relevant.
• Ask about recent stent placement, stroke, transient ischemic attack, myocardial infarction, DVT/PE, or vascular surgery.
• Check for clopidogrel, ticagrelor, prasugrel, warfarin, apixaban, rivaroxaban, dabigatran, edoxaban, NSAIDs, SSRIs/SNRIs, steroids, alcohol misuse, liver disease, or bleeding disorders.
• Plan invasive procedures early in the day and early in the week when possible.
• Limit the initial surgical field and stage complex care.
• Prepare local haemostatic materials before starting.
• Do not discharge until stable haemostasis has been achieved.

For most dental care in patients taking aspirin, local bleeding control is the main safety tool.

• Use atraumatic surgical technique.
• Remove granulation tissue when appropriate and avoid unnecessary tissue trauma.
• Apply firm gauze pressure for an adequate time.
• Use local haemostatic packing when indicated.
• Place sutures when wound size or bleeding risk justifies it.
• Consider staged treatment for multiple or complex procedures.
• Consider tranexamic acid local measures if available and appropriate under local protocol.
• Give clear written postoperative bleeding instructions.

• Aspirin is combined with clopidogrel, ticagrelor, prasugrel, warfarin, or a DOAC.
• The patient has a recent coronary stent, recent myocardial infarction, recent stroke, or unstable cardiovascular status.
• The procedure is extensive, high bleeding risk, or difficult to manage in primary dental care.
• The patient reports serious previous postoperative bleeding.
• There is liver disease, thrombocytopenia, bleeding disorder, kidney disease, alcohol misuse, or active cancer therapy.
• The patient is taking additional drugs that increase bleeding risk.
• Medical history is unclear and the procedure is elective.
• The dentist cannot provide adequate local haemostasis or follow-up.

• NSAIDs: ibuprofen, naproxen, and diclofenac can increase bleeding and gastrointestinal risk when combined with aspirin.
• Ibuprofen timing: ibuprofen can interfere with aspirin antiplatelet effect if used incorrectly; avoid routine use unless medically appropriate.
• Other antiplatelets: clopidogrel, ticagrelor, prasugrel, and dipyridamole increase bleeding risk when combined with aspirin.
• Anticoagulants: warfarin and DOACs combined with aspirin require extra bleeding-risk planning.
• Postoperative analgesia: paracetamol/acetaminophen is often preferred when suitable, with attention to liver disease and maximum daily dose.
• Antibiotics: aspirin use alone is not an indication for antibiotics.

• Do not stop aspirin unless the dentist and prescribing clinician give a clear plan.
• Bring a medication list and explain why aspirin is being taken.
• After extraction or surgery, bite firmly on gauze as instructed.
• Avoid vigorous rinsing, spitting, smoking, alcohol, and heavy exercise during the early clot-stabilization period.
• Avoid self-medicating with ibuprofen, naproxen, diclofenac, or extra aspirin unless advised.
• Use the recommended pain medicine and dose.
• Contact the clinic if bleeding restarts repeatedly or does not stop with firm pressure.
• Seek urgent help for heavy bleeding, dizziness, weakness, chest pain, stroke symptoms, or breathing difficulty.

For aspirin patients, the safest routine dental mindset is not “stop the drug.” It is “control the surgical field, limit wound size, use local haemostasis, and protect the patient from unnecessary thrombotic risk.”

• Postoperative bleeding that does not stop after firm pressure
• Repeated clot loss or mouth filling with blood
• Dizziness, faintness, weakness, pallor, or signs of significant blood loss
• Combination therapy with aspirin plus anticoagulant or second antiplatelet and uncontrolled bleeding
• Chest pain, shortness of breath, weakness on one side, facial droop, speech difficulty, or stroke-like symptoms
• Extensive hematoma, expanding swelling, or airway concern
• Severe pain, swelling, fever, pus, trismus, or spreading odontogenic infection

• Clopidogrel and Dental Treatment
• Dual Antiplatelet Therapy
• Warfarin and Dental Treatment
• Apixaban and Rivaroxaban
• Local Haemostatic Measures
• Tranexamic Acid
• Post-extraction Bleeding
• NSAID Avoidance in Bleeding-Risk Patients
• Dental Extraction Management
• Medical Consultation Before Dental Surgery

Aspirin is an antiplatelet drug used to reduce arterial thrombotic risk. In dental practice, aspirin may increase postoperative bleeding, but most bleeding can be managed with local haemostatic measures. For most dental procedures, aspirin should not be interrupted casually, especially when it is used for cardiovascular or cerebrovascular protection. The dentist should identify whether aspirin is used alone or with another antithrombotic, assess procedure bleeding risk, plan treatment early in the day, stage extensive surgery, avoid unnecessary NSAIDs, use firm pressure, packing and suturing when needed, and give written postoperative instructions. Consultation is important for recent stents, recent stroke or myocardial infarction, dual antiplatelet therapy, complex surgery, unclear history, or uncontrolled bleeding risk.